Industry sector reports

294 animal health partnerships | Deal structures and financial benchmarks | Leading dealmakers and prospective partners | Disease and technology analysis | Contract intelligence

2,448 academic and non-profit partnerships | Deal structures and financial benchmarks | Leading institutions and industry partners | Technology and therapy analysis | Contract intelligence

1,019 specialty pharmaceutical partnerships | Deal structures and financial benchmarks | Leading dealmakers and prospective partners | Therapy and technology analysis | Contract intelligence

The Leading Partnering Intelligence Platform for Life Science Dealmakers

Custom Executive Partnering Briefings apply Current Partnering’s proprietary pharma and biotech deal intelligence to your company, pipeline or strategic priorities. Each briefing delivers focused analysis of relevant deals, potential partners, financial benchmarks and market trends. Standalone briefings start from USD$3,995 with a free proposed table of contents and scope available on request.

Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2020 to 2026

Medical Device Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2026

Global Generic Pharmaceutical Partnering Terms and Agreements 2010 to 2026 report provides a detailed understanding and analysis of how and why companies enter generic pharmaceutical partnering deals. 

Provides a detailed understanding and analysis of how and why companies enter Big Pharma partnering deals

Global Biotech Partnering Terms and Agreements 2018 to 2023 report provides a detailed understanding and analysis of how and why companies enter biotech partnering deals.